Makoto Saito

8PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMedical virologyRespiratory diseasesInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 28, 2024
Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin's Lymphoma: A Single-Center Cohort Study.

Makoto Saito, Akio Mori, Takashi Ishio

|Jul 06, 2023
Booster effect of a third mRNA-based COVID-19 vaccine dose in patients with myeloid malignancies.

Akio Mori, Masahiro Onozawa, Mirei Kobayashi

|May 23, 2023
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.

Mirei Kobayashi, Akio Mori, Yoshitaka Oda

|Mar 02, 2023
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms.

Mirei Kobayashi, Akio Mori, Masahiro Onozawa

|Nov 28, 2022
Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia.

Akio Mori, Masahiro Onozawa, Mirei Kobayashi

|Nov 05, 2021
Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patients.

Akio Mori, Masahiro Onozawa, Daisuke Hidaka

Pageof 2

Frequent Collaborators

8 joint publications

Koh Izumiyama

7 joint publications

Akio Mori

7 joint publications

Takeshi Kondo

5 joint publications

Masahiro Onozawa